ESR1 and breast carcinoma: An alternative regulator of ER transcription is ARID1A, which has been shown to associate with ER and aids in the maintenance of the luminal phenotype of ER+ breast cancer cells (Nagarajan et al. 2020, Xu et al. 2020).